共 78 条
[1]
Weisenburger DD(2011)Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project Blood 117 3402-8
[2]
Savage KJ(2017)The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma Br J Haematol 176 750-8
[3]
Harris NL(2013)Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors J Clin Oncol 31 1970-6
[4]
Gascoyne RD(2009)Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study J Clin Oncol 27 106-13
[5]
Jaffe ES(2012)Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01 J Clin Oncol 30 3093-9
[6]
MacLennan KA(2017)Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers Ann Oncol 29 715-23
[7]
Chihara D(2007)The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience Ann Oncol 18 652-7
[8]
Fanale MA(2009)Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome Biol Blood Marrow Transplant 15 118-25
[9]
Miranda RN(2015)Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial J Clin Oncol 33 8507-8507
[10]
Noorani M(2017)Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation Haematologica 102 1258-65